Itaru Kato Selected Research

Itaru Kato Research Topics

Disease

16	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2022 - 02/2007
11	Neoplasms (Cancer) 07/2022 - 03/2008
7	Leukemia 07/2022 - 07/2014
6	Philadelphia Chromosome 11/2022 - 05/2015
5	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 04/2014
5	Graft vs Host Disease (Graft-Versus-Host Disease) 07/2018 - 08/2007
3	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 01/2022 - 03/2010
3	Hepatoblastoma 11/2018 - 08/2015
3	Pathologic Complete Response 01/2015 - 02/2009
2	Necrosis 03/2022 - 06/2009
2	Neoplasm Metastasis (Metastasis) 01/2022 - 04/2015
2	Epstein-Barr Virus Infections 01/2022 - 01/2022
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 01/2022 - 02/2007
2	Neuroblastoma 11/2021 - 03/2008
2	Central Nervous System Diseases (CNS Diseases) 09/2020 - 01/2016
2	Residual Neoplasm 08/2017 - 10/2009
2	Lymphoma (Lymphomas) 05/2015 - 06/2009
1	Leukoencephalopathies 11/2022
1	Erythema 07/2022
1	Hypertension (High Blood Pressure) 07/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 07/2022
1	Colorectal Neoplasms (Colorectal Cancer) 05/2022
1	Acute Liver Failure (Fulminant Hepatic Failure) 01/2022
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2022
1	Pancreatitis 08/2021
1	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021
1	Myositis (Idiopathic Inflammatory Myopathies) 01/2021
1	Teratoma (Teratoid Tumor) 01/2021
1	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL) 01/2021
1	Death (Near-Death Experience) 08/2020
1	Stomatitis 01/2020
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2020
1	Persistent Fetal Circulation Syndrome 01/2020
1	Pulmonary Hypertension 01/2020
1	Mycoses (Diseases, Fungus) 12/2019
1	Neutropenia 12/2019
1	Infections 11/2018
1	Cytomegalovirus Infections (Inclusion Disease) 11/2018
1	Hemorrhage 10/2018
1	Hemorrhagic Cystitis 01/2018
1	Germinoma 01/2018
1	GATA2 Deficiency 03/2016
1	Lymphoid Leukemia 01/2016

Drug/Important Bio-Agent (IBA)

5	Tyrosine Kinase InhibitorsIBA 07/2022 - 03/2017
4	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 03/2010
3	Chimeric Antigen ReceptorsIBA 11/2022 - 09/2020
3	Imatinib Mesylate (Gleevec)FDA Link 03/2022 - 05/2015
3	Temozolomide (Temodar)FDA LinkGeneric 01/2022 - 01/2016
3	DNA (Deoxyribonucleic Acid)IBA 03/2016 - 12/2014
2	RNA (Ribonucleic Acid)IBA 01/2022 - 01/2022
2	NF-kappa B (NF-kB)IBA 11/2021 - 06/2009
2	pazopanib FDA Link 01/2021 - 08/2017
2	Rituximab (Mabthera)FDA Link 04/2015 - 02/2010
2	Foscarnet FDA LinkGeneric 01/2015 - 12/2014
2	Cyclosporine (Ciclosporin)FDA LinkGeneric 11/2012 - 03/2010
2	SteroidsIBA 10/2010 - 03/2010
2	Prednisolone (Predate)FDA LinkGeneric 03/2010 - 08/2007
1	TransferasesIBA 07/2022
1	Alanine Transaminase (SGPT)IBA 07/2022
1	Aspartate Aminotransferases (Aspartate Transaminase)IBA 07/2022
1	ponatinibIBA 07/2022
1	cabozantinibIBA 05/2022
1	Histone Acetyltransferases (Histone Acetyltransferase)IBA 01/2022
1	Carrier Proteins (Binding Protein)IBA 01/2022
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 01/2022
1	Proteins (Proteins, Gene)FDA Link 01/2022
1	Pharmaceutical PreparationsIBA 01/2022
1	Cell Adhesion MoleculesIBA 11/2021
1	Small Interfering RNA (siRNA)IBA 11/2021
1	Focal Adhesion Protein-Tyrosine KinasesIBA 11/2021
1	CD146 AntigenIBA 11/2021
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 08/2021
1	lambda Spi-1IBA 01/2021
1	Inotuzumab OzogamicinIBA 01/2021
1	LipidsIBA 01/2021
1	CateninsIBA 01/2021
1	tisagenlecleucelIBA 02/2020
1	Melphalan (Alkeran)FDA LinkGeneric 01/2020
1	Antiviral Agents (Antivirals)IBA 11/2018
1	AntigensIBA 11/2018
1	Dasatinib (BMS 354825)FDA Link 03/2017
1	Cyclin D2IBA 01/2016
1	palbociclibIBA 01/2016

Therapy/Procedure

13	Therapeutics 11/2022 - 02/2007
10	Drug Therapy (Chemotherapy) 03/2022 - 04/2014
7	Hematopoietic Stem Cell Transplantation 01/2021 - 11/2008
7	Stem Cell Transplantation 01/2020 - 03/2008
4	Transplantation 01/2020 - 03/2010
3	Bone Marrow Transplantation (Transplantation, Bone Marrow) 11/2022 - 02/2009
3	Liver Transplantation 01/2022 - 01/2018
2	Cell Transplantation 01/2022 - 08/2014
2	Aftercare (After-Treatment) 01/2021 - 12/2014
2	Salvage Therapy 08/2020 - 08/2017
2	Combination Drug Therapy (Combination Chemotherapy) 01/2016 - 04/2015
1	Immunotherapy 01/2022
1	Blood Component Removal (Apheresis) 01/2022
1	Deep Sedation 08/2020
1	Cryotherapy (Therapy, Cold) 01/2020
1	Lung Transplantation 01/2020
1	Re-Irradiation 01/2018